Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Ciotti

Showing results (141-150 of 148) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 148 results.
Diagnostics (Basel, Switzerland)|August 26, 2022
Predictive Value of MR-proADM in the Risk Stratification and in the Adequate Care Setting of COVID-19 Patients Assessed at the Triage of the Emergency DepartmentMarilena Minieri, Vito N Di Lecce, Maria Stella Lia, et al.
Biomolecules|July 27, 2022
Infection Rate of Respiratory Viruses in the Pandemic SARS-CoV-2 Period Considering Symptomatic Patients: Two Years of Ongoing ObservationsGaetana Costanza, Pierpaolo Paba, Marco Ciotti, et al.
Journal of Clinical Medicine|January 21, 2022
Diagnostic Value of JC Polyomavirus Viruria, Viremia, Serostatus and microRNA Expression in Multiple Sclerosis Patients Undergoing Immunosuppressive TreatmentCarla Prezioso, Marco Ciotti, Gabriele Brazzini, et al.
Frontiers in Pharmacology|July 5, 2021
Lactoferrin Against SARS-CoV-2: <i>In Vitro</i> and <i>In Silico</i> EvidencesElena Campione, Caterina Lanna, Terenzio Cosio, et al.
International Journal of Environmental Research and Public Health|October 23, 2021
Lactoferrin as Antiviral Treatment in COVID-19 Management: Preliminary EvidenceElena Campione, Caterina Lanna, Terenzio Cosio, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|November 9, 2023
Prevalence of hepatitis D virus infection in Central Italy has remained stable across the last 2 decades with dominance of subgenotypes 1 and characterized by elevated viral replicationRomina Salpini, Lorenzo Piermatteo, Giulia Torre, et al.
Carcinogenesis|February 14, 2014
HPV-associated lung cancers: an international pooled analysisCamille Ragin, Monisola Obikoya-Malomo, Sungjin Kim, et al.
The Lancet. Oncology|July 24, 2009
TP53 codon 72 polymorphism and cervical cancer: a pooled analysis of individual data from 49 studiesStefanie J Klug, Meike Ressing, Jochem Koenig, et al.
Pageof 15

Showing results (141-150 of 148) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 148 results.
Diagnostics (Basel, Switzerland)|August 26, 2022
Predictive Value of MR-proADM in the Risk Stratification and in the Adequate Care Setting of COVID-19 Patients Assessed at the Triage of the Emergency DepartmentMarilena Minieri, Vito N Di Lecce, Maria Stella Lia, et al.
Biomolecules|July 27, 2022
Infection Rate of Respiratory Viruses in the Pandemic SARS-CoV-2 Period Considering Symptomatic Patients: Two Years of Ongoing ObservationsGaetana Costanza, Pierpaolo Paba, Marco Ciotti, et al.
Journal of Clinical Medicine|January 21, 2022
Diagnostic Value of JC Polyomavirus Viruria, Viremia, Serostatus and microRNA Expression in Multiple Sclerosis Patients Undergoing Immunosuppressive TreatmentCarla Prezioso, Marco Ciotti, Gabriele Brazzini, et al.
Frontiers in Pharmacology|July 5, 2021
Lactoferrin Against SARS-CoV-2: <i>In Vitro</i> and <i>In Silico</i> EvidencesElena Campione, Caterina Lanna, Terenzio Cosio, et al.
International Journal of Environmental Research and Public Health|October 23, 2021
Lactoferrin as Antiviral Treatment in COVID-19 Management: Preliminary EvidenceElena Campione, Caterina Lanna, Terenzio Cosio, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|November 9, 2023
Prevalence of hepatitis D virus infection in Central Italy has remained stable across the last 2 decades with dominance of subgenotypes 1 and characterized by elevated viral replicationRomina Salpini, Lorenzo Piermatteo, Giulia Torre, et al.
Carcinogenesis|February 14, 2014
HPV-associated lung cancers: an international pooled analysisCamille Ragin, Monisola Obikoya-Malomo, Sungjin Kim, et al.
The Lancet. Oncology|July 24, 2009
TP53 codon 72 polymorphism and cervical cancer: a pooled analysis of individual data from 49 studiesStefanie J Klug, Meike Ressing, Jochem Koenig, et al.
Pageof 15